Intestinal mucosal MMP-1 – a prognostic factor in colon cancer

References

• Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479–82.
   PubMed Web of Science ®Google Scholar
• Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009;92:148–63.
   PubMed Web of Science ®Google Scholar
• Macdonald JS. Adjuvant therapy of colon cancer. CA Cancer J Clin 1999;49:202–19.
   PubMed Web of Science ®Google Scholar
• Galanis E, Alberts SR, O'Connell MJ. New adjuvant therapy for colon cancer: justified hope or commercial hype. Surg Oncol Clin N Am 2000;9:813–23; discussion 25-6.
   Google Scholar
• Chung DC. Molecular prognostic markers and colorectal cancer: the search goes on. Gastroenterology 1998;114:1330–2.
   PubMedGoogle Scholar
• Li FY, Lai MD. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009;10:219–29.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol 2005;2:416–22.
   PubMedGoogle Scholar
• Valastyan S, Weinberg Robert A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011;147:275–92.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol 2008;214:283–93.
   PubMed Web of Science ®Google Scholar
• Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004;1705:69–89.
   PubMed Web of Science ®Google Scholar
• Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995;4:21–9.
   Google Scholar
• Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 1995;72:575–82.
   PubMed Web of Science ®Google Scholar
• Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007;42:113–85.
   PubMed Web of Science ®Google Scholar
• Chu D, Zhao Z, Zhou Y, Li Y, Li J, Zheng J, Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol 2012;19:318–25.
   Google Scholar
• Langers AM, Verspaget HW, Hawinkels LJ, Kubben FJ, van Duijn W, van der Reijden JJ, MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. Br J Cancer 2012;106:1495–8.
   Web of Science ®Google Scholar
• Langenskiold M, Holmdahl L, Falk P, Angenete E, Ivarsson ML. Increased TGF-beta1 protein expression in patients with advanced colorectal cancer. J Surg Oncol 2008;97:409–15.
   PubMed Web of Science ®Google Scholar
• Angenete E, Oresland T, Falk P, Breimer M, Hultborn R, Ivarsson ML. Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components. Acta Oncol 2009;48:1144–51.
   PubMed Web of Science ®Google Scholar
• Langenskiold M. Tissue remodelling proteases as prognostic factors in colon and rectal cancer. Gothenburg: Gothenburg University; 2009.
   Google Scholar
• Holmdahl L, Kotseos K, Bergstrom M, Falk P, Ivarsson ML, Chegini N. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Surgery 2001;129:626–32.
   PubMed Web of Science ®Google Scholar
• Langers AM, Sier CF, Hawinkels LJ, Kubben FJ, van Duijn W, van der Reijden JJ, MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. Br J Cancer 2008;98:1820–3.
   Web of Science ®Google Scholar
• Boland CR, Kim YS. Transitional mucosa of the colon and tumor growth factors. Med Hypotheses 1987;22:237–43.
   Google Scholar
• Edelstein PS, Thompson SM, Davies RJ. Altered intracellular calcium regulation in human colorectal cancers and in “normal” adjacent mucosa. Cancer Res 1991;51:4492–4.
   Google Scholar
• Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564–7.
   PubMed Web of Science ®Google Scholar
• von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63–73.
   PubMed Web of Science ®Google Scholar
• Salmela MT, Pender SL, Karjalainen-Lindsberg ML, Puolakkainen P, Macdonald TT, Saarialho-Kere U. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 2004;39:1095–104.
   PubMed Web of Science ®Google Scholar
• Rouy D, Ernens I, Jeanty C, Wagner DR. Plasma storage at −80°C does not protect matrix metalloproteinase-9 from degradation. Anal Biochem 2005;338:294–8.
   PubMed Web of Science ®Google Scholar
• Hilska M, Roberts PJ, Collan YU, Laine VJ, Kossi J, Hirsimaki P, Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer 2007;121:714–23.
   PubMedGoogle Scholar
• Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 2001;7:1258–62.
   PubMed Web of Science ®Google Scholar
• Sanz-Pamplona R, Cordero D, Berenguer A, Lejbkowicz F, Rennert H, Salazar R, Gene expression differences between colon and rectum tumors. Clin Cancer Res 2011;17:7303–12.
   PubMed Web of Science ®Google Scholar
• Odin E, Wettergren Y, Nilsson S, Willen R, Carlsson G, Spears CP, Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res 2003;9(16 Pt 1):6012–19.
   Google Scholar
• Shamsuddin AK, Weiss L, Phelps PC, Trump BF. Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. J Natl Cancer Inst 1981;66:413–19.
   PubMedGoogle Scholar
• Terpstra OT, van Blankenstein M, Dees J, Eilers GA. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704–8.
   PubMed Web of Science ®Google Scholar